CDT Equity (CDT) Treasury Shares (2021 - 2025)

CDT Equity's (CDT) quarterly Treasury Shares came in at $106000.0 in Q2 2025.

CDT Equity (CDT) Treasury Shares (2021 - 2025) Analysis & Trends

CDT Equity (CDT) has 3 years of Treasury Shares data on file, last reported at $72.4 million in Q3 2023.

Quarterly Treasury Shares rose 447.59% year-over-year to $72.4 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $72.4 million (up 447.59% YoY) and the FY2022 annual result came in at $13.2 million, changed 0.0% from the prior year.
Treasury Shares steadied at $106000.0 in Q2 2025.
In the past five years, Treasury Shares ranged from a high of $72.4 million in Q3 2023 to a low of $2.2 million in Q1 2023.
A 3-year average of $17.9 million and a median of $13.2 million in 2021 frame the typical range for Treasury Shares.
The widest YoY moves for Treasury Shares: up 447.59% in 2023, down 83.46% in 2023.
Tracing CDT's Treasury Shares over 3 years: stood at $13.2 million in 2021, then changed by 0.0% to $13.2 million in 2022, then soared by 447.59% to $72.4 million in 2023.
The last three Treasury Shares figures came in at $72.4 million (Q3 2023), $2.2 million (Q2 2023), and $2.2 million (Q1 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	CDT Equity	1.55 Mn	1.55 Mn	-	-

Download Data